Company Tonix Pharmaceuticals Holding Corp Nasdaq
Equities
US8902602015
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
|
09/07 | Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge | MT |
09/07 | Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,454,345 | 17,158,681 ( 98.31 %) | 0 | 98.31 % |
Company contact information
Tonix Pharmaceuticals Holding Corp.
26 Main Street Suite 101
07928, Chatham
+862 799 8599
http://www.tonixpharma.com![address Tonix Pharmaceuticals Holding Corp](https://cdn.zonebourse.com/static/address/13919289.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+7.64% | 10TCr | |
+7.76% | 4.22TCr | |
-14.37% | 3.23TCr | |
+82.32% | 2.98TCr | |
-12.27% | 1.61TCr | |
+2.33% | 1.44TCr | |
-8.56% | 1.2TCr | |
+182.74% | 1.07TCr | |
+3.67% | 889.02Cr |
- Stock Market
- Equities
- TNXP Stock
- Stock
- Company Tonix Pharmaceuticals Holding Corp